Company Description
Rennova Health (OTC Link: RNVA) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $4.3M.
RNVA stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of RNVA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Rennova Health (RNVA) stock last traded at $0.0000. At a market capitalization of $4.3M, RNVA is classified as a micro-cap stock with approximately 43.1B shares outstanding.
Latest News
Rennova Health has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all RNVA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Rennova Health (RNVA) currently stands at 3 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Rennova Health (RNVA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
RNVA Company Profile & Sector Positioning
Rennova Health (RNVA) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RNVA often look at related companies in the same sector, including Imd Companies (ICBU), Hypha Labs (FUNI), Leveljump Health (JMPHF), Interpace Biosciences Inc (IDXG), and Stagezero Life (SZLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNVA's relative position within its industry.